Post-approval studies (Phase 4)Study completedNCT01638715
What this trial is testing
A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
Who this might be right for
Rheumatoid Arthritis
Medical University of Vienna 115